Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Soligenix (SNGX) Stock Price & Analysis

SNGX Stock Chart & Stats

$0.36-$0.01(-3.79%)
At close: 4:00 PM EDT
$0.35$0.375$0.43 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$0.34 - $0.38
52-Week Range
$0.28 - $1.70
Previous Close
$0.37
Volume
151.23K
Average Volume (3M)
153.56K
Market Cap
$7.75M
Enterprise Value
-$3.19M
Total Cash (Recent Filing)
$9.81M
Total Debt (Recent Filing)
$302.59K
Price to Earnings (P/E)
―
Beta
0.26
Next Earnings
Nov 06, 2026 (Est.)
EPS Estimate
-0.1
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage And Rebuilt Equity

Modest leverage and rebuilt equity provide a stronger capital structure than in earlier periods, reducing debt-related pressure and preserving some flexibility for clinical development. This is a meaningful cushion, although continued losses could erode it over time.

Focus On Rare Diseases And Biodefense

A pipeline aimed at rare diseases, unmet medical needs, and biodefense addresses areas where specialized treatments and preparedness products may have durable strategic relevance. This focus can support differentiated development opportunities if candidates achieve clinical and commercial validation.

Losses Largely Reflect Cash Costs

The close relationship between free cash flow and net loss offers clearer visibility into the company’s underlying cash economics, because reported losses are not being materially distorted by non-cash accounting items. That transparency can aid financing and operating decisions.

Bears Say

Pre-revenue Model With Widening Losses

The absence of meaningful revenue leaves the company without an established commercial earnings base, while widening losses show that spending has not yet translated into operating scale. Until products generate revenue, profitability remains dependent on successful development and future financing.

Persistent Cash Burn And Funding Dependence

Sustained negative operating cash flow requires continuing access to external capital, increasing financing risk and potentially diluting shareholders. The expanded ATM program and prior stock sales demonstrate that funding operations remains an ongoing requirement rather than a temporary need.

Pipeline Setback And Delisting Pressure

Ending a Phase 3 program after a futility recommendation removes an important potential value driver and narrows the development base. Nasdaq bid-price noncompliance adds a separate listing risk that can complicate financing, investor access, and strategic execution.

Soligenix News

SNGX FAQ

What was Soligenix’s price range in the past 12 months?
Soligenix lowest stock price was $0.28 and its highest was $1.70 in the past 12 months.
What is Soligenix’s market cap?
Soligenix’s market cap is $7.75M.
When is Soligenix’s upcoming earnings report date?
Soligenix’s next earnings report is estimated for Nov 06, 2026 (not yet confirmed), which is in 4 days.
How were Soligenix’s earnings last quarter?
Soligenix released its earnings results on Aug 07, 2026. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.155 by $0.035.
Is Soligenix overvalued?
According to Wall Street analysts Soligenix’s price is currently Undervalued.
Does Soligenix pay dividends?
Soligenix does not currently pay dividends.
What is Soligenix’s EPS estimate?
Soligenix’s EPS estimate is -0.10.
How many shares outstanding does Soligenix have?
Soligenix has 21,765,478 shares outstanding.
What happened to Soligenix’s price movement after its last earnings report?
Soligenix reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.155. Following the earnings report the stock price went up 3.704%.
Which hedge fund is a major shareholder of Soligenix?
Hedge funds hold Soligenix shares: the largest hedge-fund position in Soligenix is 71,877,785 shares, and hedge funds decreased their holdings by 1.0 shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology